SHENZHEN KANGTAI BIOLOGICAL PRODUCTS CO., LTD.

Altre lingue Shenzhen Kangtai Biological Products Co., Ltd.

Azioni

300601

CNE100002Q33

Prezzo di chiusura Shenzhen S.E. Altri mercati azionari 00:00:00 15/04/2024			Variaz. 5gg	Var. 1 gen.
20,55 ^CNY	-1,96%		-4,20%	-24,31%

10/01	Kangtai Biological prevede di tornare all'utile nel 2023	MT
2023	Shenzhen Kangtai Biological Products Co., Ltd. riporta i risultati degli utili per i nove mesi conclusi il 30 settembre 2023	CI

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

Kangtai Biological Forecasts Swing to Profit in 2023	10/01
Shenzhen Kangtai Biological Products Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	26/10/23
Shenzhen Kangtai Biological Products Co., Ltd. Announces Interim Profit Distribution Plan to Be Implemented (A Shares) for 2023, Payable on 13 October 2023	09/10/23
Shenzhen Kangtai Biological Products Co., Ltd. Approves 2023 Interim Cash Dividend	27/09/23
Kangtai Signs Deal to Distribute Varicella Vaccine in Pakistan, India	20/09/23
Shenzhen Kangtai Biological Products Co., Ltd. Proposes Interim Cash Dividend for the First Half of 2023	28/08/23
Shenzhen Kangtai Biological Products Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	25/08/23
Kangtai Biological Partners With Indian Drugmaker to Distribute Pneumococcal Vaccine	31/05/23
Shenzhen Kangtai Biological Products Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	23/04/23
Tranche Update on Shenzhen Kangtai Biological Products Co., Ltd.'s Equity Buyback Plan announced on October 12, 2022.	15/03/23
Shenzhen Kangtai Biological Products Co., Ltd.'s Equity Buyback announced on October 12, 2022 has closed with 3,581,600 shares, representing 0.32% for CNY 120.97 million.	13/03/23
Shenzhen Kangtai Biological sees 2022 net loss on weaker COVID shot demand	10/01/23
Tranche Update on Shenzhen Kangtai Biological Products Co., Ltd.'s Equity Buyback Plan announced on October 12, 2022.	03/01/23
Shares in Chinese Pharma Companies Decline Amid Drop in Vaccination Rates	29/12/22
Shenzhen Kangtai Biological Products Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	27/10/22
Tranche Update on Shenzhen Kangtai Biological Products Co., Ltd.'s Equity Buyback Plan announced on October 12, 2022.	12/10/22
Shenzhen Kangtai Biological Products Co., Ltd. commences an Equity Buyback Plan for CNY 200 million worth of its shares, under the authorization approved on September 14, 2022.	12/10/22
China's CanSinoBIO H1 revenue drops on weaker COVID shot demand	29/08/22
Shenzhen Kangtai Biological Products Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	18/08/22
Shenzhen Kangtai Biological Products Co., Ltd. authorizes a Buyback Plan.	18/08/22

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Shenzhen Kangtai Biological Products Co., Ltd.

Azioni

300601

CNE100002Q33

Altre lingue

Filtri